These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 28356736

  • 1. Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis.
    Want MY, Islammudin M, Chouhan G, Ozbak HA, Hemeg HA, Chattopadhyay AP, Afrin F.
    Int J Nanomedicine; 2017; 12():2189-2204. PubMed ID: 28356736
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis.
    Want MY, Islamuddin M, Chouhan G, Ozbak HA, Hemeg HA, Dasgupta AK, Chattopadhyay AP, Afrin F.
    Colloids Surf B Biointerfaces; 2015 Jun 01; 130():215-21. PubMed ID: 25936561
    [Abstract] [Full Text] [Related]

  • 3. A new approach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studies.
    Want MY, Islamuddin M, Chouhan G, Dasgupta AK, Chattopadhyay AP, Afrin F.
    J Colloid Interface Sci; 2014 Oct 15; 432():258-69. PubMed ID: 25086720
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of artemisinin in experimental visceral leishmaniasis.
    Sen R, Ganguly S, Saha P, Chatterjee M.
    Int J Antimicrob Agents; 2010 Jul 15; 36(1):43-9. PubMed ID: 20403680
    [Abstract] [Full Text] [Related]

  • 5. A novel outlook in the delivery of artemisinin: production and efficacy in experimental visceral leishmaniasis.
    Akbari M, Heli H, Oryan A, Hatam G.
    Pathog Glob Health; 2024 Feb 15; 118(1):40-46. PubMed ID: 37183476
    [Abstract] [Full Text] [Related]

  • 6. Nanoliposomal Buparvaquone Immunomodulates Leishmania infantum-Infected Macrophages and Is Highly Effective in a Murine Model.
    da Costa-Silva TA, Galisteo AJ, Lindoso JA, Barbosa LR, Tempone AG.
    Antimicrob Agents Chemother; 2017 Apr 15; 61(4):. PubMed ID: 28167544
    [Abstract] [Full Text] [Related]

  • 7. Targeting intracellular Leishmania (L.) infantum with nitazoxanide entrapped into phosphatidylserine-nanoliposomes: An experimental study.
    Pinto EG, Barbosa LRS, Mortara RA, Tempone AG.
    Chem Biol Interact; 2020 Dec 01; 332():109296. PubMed ID: 33096056
    [Abstract] [Full Text] [Related]

  • 8. Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.
    Roychoudhury J, Sinha R, Ali N.
    PLoS One; 2011 Mar 10; 6(3):e17376. PubMed ID: 21423750
    [Abstract] [Full Text] [Related]

  • 9. Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis.
    Romanelli MM, da Costa-Silva TA, Cunha-Junior E, Dias Ferreira D, Guerra JM, Galisteo AJ, Pinto EG, Barbosa LRS, Torres-Santos EC, Tempone AG.
    Front Cell Infect Microbiol; 2019 Mar 10; 9():353. PubMed ID: 31737574
    [Abstract] [Full Text] [Related]

  • 10. Artemisinin efficacy against old world Leishmania donovani: in vitro and ex vivo study.
    Al-HAlbosiy MMF, Ali HZ, Hassan GM, Ghaffarifar F.
    Ann Parasitol; 2020 Mar 10; 63(3):295-302. PubMed ID: 33128446
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
    Islamuddin M, Chouhan G, Want MY, Ozbak HA, Hemeg HA, Afrin F.
    PLoS Negl Trop Dis; 2016 Oct 10; 10(10):e0005011. PubMed ID: 27776125
    [Abstract] [Full Text] [Related]

  • 12. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S, Ghosh P, De T, Gomes A, Gomes A, Dungdung SR.
    Exp Parasitol; 2013 Sep 10; 135(1):126-33. PubMed ID: 23830987
    [Abstract] [Full Text] [Related]

  • 13. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
    Charan Raja MR, Velappan AB, Chellappan D, Debnath J, Kar Mahapatra S.
    Eur J Med Chem; 2017 Oct 20; 139():503-518. PubMed ID: 28826085
    [Abstract] [Full Text] [Related]

  • 14. Chlorogenic acid acts upon Leishmania donovani arresting cell cycle and modulating cytokines and nitric oxide in vitro.
    Majumder N, Ganguly S, Ghosh AK, Kundu S, Banerjee A, Saha S.
    Parasite Immunol; 2020 Jun 20; 42(6):e12719. PubMed ID: 32248547
    [Abstract] [Full Text] [Related]

  • 15. Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis.
    Parvez S, Yadagiri G, Gedda MR, Singh A, Singh OP, Verma A, Sundar S, Mudavath SL.
    Sci Rep; 2020 Jul 22; 10(1):12243. PubMed ID: 32699361
    [Abstract] [Full Text] [Related]

  • 16. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P, Parmar N, Yadav PK, Chandrakar P, Kar S.
    J Mol Med (Berl); 2016 Jun 22; 94(6):695-710. PubMed ID: 26830627
    [Abstract] [Full Text] [Related]

  • 17. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.
    Sinha R, Roychoudhury J, Palit P, Ali N.
    Antimicrob Agents Chemother; 2015 Jan 22; 59(1):344-55. PubMed ID: 25367907
    [Abstract] [Full Text] [Related]

  • 18. Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis.
    Mallick S, Halder S, Dutta A, Dey S, Paul K, Maiti S, Bandyopadhyay C, Saha B, Pal C.
    Int Immunopharmacol; 2013 Apr 22; 15(4):772-9. PubMed ID: 23499679
    [Abstract] [Full Text] [Related]

  • 19. Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis.
    Gupta S, Yardley V, Vishwakarma P, Shivahare R, Sharma B, Launay D, Martin D, Puri SK.
    J Antimicrob Chemother; 2015 Feb 22; 70(2):518-27. PubMed ID: 25389223
    [Abstract] [Full Text] [Related]

  • 20. Critical Antileishmanial in vitro Effects of Highly Examined Gold Nanoparticles.
    Want MY, Yadav P, Khan R, Chouhan G, Islamuddin M, Aloyouni SY, Chattopadhyay AP, AlOmar SY, Afrin F.
    Int J Nanomedicine; 2021 Feb 22; 16():7285-7295. PubMed ID: 34737566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.